Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Researchers seek to predict markers of the state of obesity, the risk of associated complications and the response to diet or bariatric surgery.
Read Full NewsMind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Benjamin Tolchin, MD, MS, FAAN. [LISTEN TIME: 23 minutes]
Alixorexton, an oral investigational selective orexin 2 receptor agonist, is currently in development for the treatment of narcolepsy type 1 and type 2, and idiopathic hypersomnia.
1.
Unlocking the potential of targeted therapies for multiple myeloma
2.
FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.
3.
Study finds common genetic target may halt breast cancer cell growth
4.
Medical Journal March 29, 2023
5.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
1.
New Frontiers in Diagnosing and Managing Myelodysplastic Syndromes (MASLD)
2.
Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment
3.
The Surprising Role of Magnesium in Digestion, Sleep and Mental Health
4.
Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics
5.
Radiation Oncology Advances: Guidelines, Trials, Digital Tools & Education
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge